TOURMALINE BIO INC. - COMMON STOCK

17,82

23-апреля-25 16:45:00

15 мин. задержка

Акции

+0,50

+2,89%

Сегодняшний диапазон

17,56 - 18,41

ISIN

N/A

Источник

NASDAQ

Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

01 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

29 янв 2024 16:01:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio Announces Pricing of Public Offering of Common Stock

25 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio Announces Proposed Public Offering of Common Stock

24 янв 2024 16:05:48 Источник Nasdaq GlobeNewswire
Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)

08 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio added to the NASDAQ Biotechnology Index

15 дек 2023 16:00:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board

14 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.